Applied Clinical Trials
October 01, 2010
Global News
0
0
Pharmacists and patient groups welcome the new European Union directive on pharmacovigilance.
October 01, 2010
Feature Article
0
0
Collecting too many metrics can lead to misappropriation and misinterpretation.
October 01, 2010
Business News
0
0
Industry news focusing on the people and organizations who work in the clinical trials profession.
October 01, 2010
View from Brussels
0
0
Routine inspections and regulations can help maintain GCP standards in global trials.
October 01, 2010
View from Washington
0
0
Reform law requires tracking and disclosure of fees to investigators and research consultants.
October 01, 2010
Technology Viewpoint
0
0
Access to all available medical evidence can profoundly improve treatment effectiveness.
October 01, 2010
0
0
Clinical grant expenditures represent a major portion of the budget for later phase clinical trials.
October 01, 2010
Feature Article
0
0
Waiving inclusion/exclusion criteria affects investigators, subjects, sponsors, and the trial itself.
October 01, 2010
A Closing Thought
0
0
The act creates serious concerns about the industry's ability to recruit and retain well-qualified investigators.
October 01, 2010
Feature Article
0
0
Knowing when to outsource and when to conduct pharmacovigilance in-house is a crucial decision.